Home

Top Picks

Treatment Selection: A Focus on Prognostic Indicators

Eunice S. Wang, MD

Review of evolving treatment approaches in pediatric patients with newly diagnosed AML

Review of evolving treatment approaches in pediatric patients with newly diagnosed AML

Richard Aplenc, MD, PhD, MSCE

What are the treatment options for children with newly diagnosed treatment-related AML?

What are the treatment options for children with newly diagnosed treatment-related AML?

E. Anders Kolb, MD

What are the latest updates in the Phase 3 study of gilteritinib and AZA vs AZA alone for ND FLT-3 AML in patients ineligible for induction chemotherapy?

MediCom Oncology Links

Please visit these other members of the MediCom Oncology family of sites.

Managing MDS

Managing Myeloma

Managing MPN

The Practical Oncologist

Managing Lymphoma

The Practical Hematologist